MedPath

Investigating the effect of finasteride and zinc supplement on hair loss after covid-19 infectio

Phase 4
Recruiting
Conditions
hair loss.
Nonscarring hair loss, unspecified
L65.9
Registration Number
IRCT20230531058350N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

All those who have been infected with Covid-19 for more than 6 months
Noticeable hair loss

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determining the comparative effect of zinc supplementation along with finasteride and zinc supplementation alone on the treatment of patients with hair loss after contracting the covid-19 disease. Timepoint: Three months after the intervention. Method of measurement: The opinion of two dermatologist separately.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath